Ultragenyx is a startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
Ultragenyx is a company headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Ultragenyx is a biopharmaceutical company that discovers, develops, and commercializes therapies for rare and ultra-rare genetic diseases. Its programs include biologics and gene therapy approaches to address enzyme deficiencies and other inherited disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.